Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study ; day:24 ; month:9 ; year:2020 ; pages:1-9
Journal of neurology ; (24.9.2020), 1-9
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-10234-6
- URN
-
urn:nbn:de:101:1-2020111220253870369214
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lindholm, Beata
- Brogårdh, Christina
- Odin, Per
- Hagell, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease